Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Lipidomics reveals a remarkable diversity of lipids in human plasma.
|
J Lipid Res
|
2010
|
4.14
|
2
|
Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry.
|
Methods
|
2005
|
3.42
|
3
|
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
|
Clin Cancer Res
|
2006
|
3.40
|
4
|
Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy.
|
Biochim Biophys Acta
|
2006
|
3.10
|
5
|
Ceramide content is increased in skeletal muscle from obese insulin-resistant humans.
|
Diabetes
|
2004
|
2.86
|
6
|
Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers.
|
J Lipid Res
|
2008
|
2.62
|
7
|
A mouse macrophage lipidome.
|
J Biol Chem
|
2010
|
2.14
|
8
|
Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors.
|
J Biol Chem
|
2003
|
2.06
|
9
|
Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals.
|
J Biol Chem
|
2008
|
1.69
|
10
|
Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.
|
Anal Chem
|
2008
|
1.69
|
11
|
Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize.
|
J Nutr
|
2004
|
1.64
|
12
|
Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics.
|
Methods Enzymol
|
2007
|
1.63
|
13
|
Non-infectious aortitis: an important cause of severe aortic regurgitation.
|
Asian Cardiovasc Thorac Ann
|
2006
|
1.52
|
14
|
Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults.
|
JAMA
|
2005
|
1.51
|
15
|
Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border.
|
Environ Health Perspect
|
2006
|
1.47
|
16
|
Subcellular organelle lipidomics in TLR-4-activated macrophages.
|
J Lipid Res
|
2010
|
1.46
|
17
|
N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing.
|
Mol Cancer Ther
|
2008
|
1.37
|
18
|
Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis.
|
J Biol Chem
|
2003
|
1.32
|
19
|
Kdo2-lipid A, a TLR4-specific agonist, induces de novo sphingolipid biosynthesis in RAW264.7 macrophages, which is essential for induction of autophagy.
|
J Biol Chem
|
2010
|
1.29
|
20
|
Elevation of sulfatides in ovarian cancer: an integrated transcriptomic and lipidomic analysis including tissue-imaging mass spectrometry.
|
Mol Cancer
|
2010
|
1.19
|
21
|
Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease.
|
J Lipid Res
|
2008
|
1.19
|
22
|
Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway.
|
Autophagy
|
2009
|
1.16
|
23
|
The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency.
|
Stem Cells
|
2006
|
1.15
|
24
|
Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis.
|
J Lipid Res
|
2007
|
1.14
|
25
|
High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines.
|
Cancer Lett
|
2006
|
1.13
|
26
|
Steroidogenic factor-1 is a sphingolipid binding protein.
|
Mol Cell Endocrinol
|
2006
|
1.12
|
27
|
Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
|
Biochim Biophys Acta
|
2002
|
1.08
|
28
|
Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action.
|
Pharmacol Res
|
2003
|
1.08
|
29
|
Conserved transcription factor binding sites of cancer markers derived from primary lung adenocarcinoma microarrays.
|
Nucleic Acids Res
|
2005
|
1.07
|
30
|
Cost savings in migraine associated with less chest pain on new triptan therapy.
|
Am J Manag Care
|
2002
|
1.07
|
31
|
Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-golgi trafficking of ceramide.
|
Mol Cell Biol
|
2006
|
1.07
|
32
|
Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers.
|
Cancer
|
2003
|
1.02
|
33
|
Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels.
|
J Biol Chem
|
2011
|
0.99
|
34
|
In vitro evaluation of dimethane sulfonate analogues with potential alkylating activity and selective renal cell carcinoma cytotoxicity.
|
Mol Cancer Ther
|
2004
|
0.99
|
35
|
A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.
|
Vaccine
|
2009
|
0.98
|
36
|
Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain.
|
J Biol Chem
|
2011
|
0.93
|
37
|
Canadian Association for Immunization Research and Evaluation (CAIRE) guidelines for industry-sponsored clinical trial and epidemiology contract research.
|
Hum Vaccin
|
2005
|
0.93
|
38
|
Prevention of fumonisin B1-induced neural tube defects by folic acid.
|
Teratology
|
2002
|
0.89
|
39
|
Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance.
|
Cancer Res
|
2002
|
0.88
|
40
|
Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel.
|
Antimicrob Agents Chemother
|
2007
|
0.86
|
41
|
Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression.
|
Mol Endocrinol
|
2012
|
0.85
|
42
|
Hydrolyzed fumonisins HFB1 and HFB2 are acylated in vitro and in vivo by ceramide synthase to form cytotoxic N-acyl-metabolites.
|
Mol Nutr Food Res
|
2007
|
0.84
|
43
|
Multiple pulmonary metastases from benign pleomorphic adenoma.
|
Asian Cardiovasc Thorac Ann
|
2008
|
0.83
|
44
|
A rare cause of constrictive pericarditis: primary cardiac lymphoma.
|
Int J Cardiol
|
2007
|
0.83
|
45
|
Effects of sphingosine-1-phosphate and ceramide-1-phosphate on rat intestinal smooth muscle cells: implications for postoperative ileus.
|
FASEB J
|
2006
|
0.82
|
46
|
Imaging MALDI mass spectrometry of sphingolipids using an oscillating capillary nebulizer matrix application system.
|
Methods Mol Biol
|
2010
|
0.82
|
47
|
Treatment and outcome of biopsy-proven fulminant myocarditis in adults.
|
Int J Cardiol
|
2005
|
0.81
|
48
|
Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor.
|
Mol Cell Biol
|
2012
|
0.80
|
49
|
Serine palmitoyltransferase subunit 1 is present in the endoplasmic reticulum, nucleus and focal adhesions, and functions in cell morphology.
|
Biochim Biophys Acta
|
2009
|
0.78
|
50
|
Age-dependent changes in the sphingolipid composition of mouse CD4+ T cell membranes and immune synapses implicate glucosylceramides in age-related T cell dysfunction.
|
PLoS One
|
2012
|
0.78
|
51
|
Computationally predicting rate constants in pathway models.
|
Conf Proc IEEE Eng Med Biol Soc
|
2005
|
0.77
|
52
|
Bronchiolitis.
|
Clin Evid
|
2002
|
0.75
|
53
|
Primary cardiac angiosarcoma of left atrium.
|
J Card Surg
|
2009
|
0.75
|
54
|
Cardiac amyloidosis - experience in a tertiary cardiac referral centre.
|
Int J Cardiol
|
2007
|
0.75
|